Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hu, Jianping"" wg kryterium: Autor


Tytuł :
Structural characterization of the Plasmodium falciparum lactate transporter PfFNT alone and in complex with antimalarial compound MMV007839 reveals its inhibition mechanism.
Autorzy :
Peng X; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
Wang N; State Key Laboratory of Membrane Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.
Zhu A; State Key Laboratory of Membrane Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.
Xu H; State Key Laboratory of Membrane Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.
Li J; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
Zhou Y; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
Wang C; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
Xiao Q; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
Guo L; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
Liu F; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.; West China School of Pharmacy, Sichuan University, Chengdu, China.
Jia ZJ; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.; West China School of Pharmacy, Sichuan University, Chengdu, China.
Duan H; School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China.
Hu J; School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China.
Yuan W; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.; Department of Laboratory Medicine, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China.
Geng J; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.; Department of Laboratory Medicine, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China.
Yan C; State Key Laboratory of Membrane Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.
Jiang X; School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, Australia.
Deng D; Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło :
PLoS biology [PLoS Biol] 2021 Sep 09; Vol. 19 (9), pp. e3001386. Date of Electronic Publication: 2021 Sep 09 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Progression of myopia in a natural cohort of Chinese children during COVID-19 pandemic.
Autorzy :
Ma D; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, NO.1 Dongjiaominxiang Street, Dongcheng District, Beijing, 100730, China.
Wei S; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, NO.1 Dongjiaominxiang Street, Dongcheng District, Beijing, 100730, China.
Li SM; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, NO.1 Dongjiaominxiang Street, Dongcheng District, Beijing, 100730, China.
Yang X; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, NO.1 Dongjiaominxiang Street, Dongcheng District, Beijing, 100730, China.
Cao K; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, NO.1 Dongjiaominxiang Street, Dongcheng District, Beijing, 100730, China.
Hu J; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, NO.1 Dongjiaominxiang Street, Dongcheng District, Beijing, 100730, China.
Fan S; Handan City Eye Hospital, Handan, 056000, China.
Zhang L; Handan City Eye Hospital, Handan, 056000, China.
Wang N; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, NO.1 Dongjiaominxiang Street, Dongcheng District, Beijing, 100730, China. .
Pokaż więcej
Źródło :
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2021 Sep; Vol. 259 (9), pp. 2813-2820. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Myopia*/diagnosis
Myopia*/epidemiology
Child ; China/epidemiology ; Disease Progression ; Humans ; Pandemics ; Refraction, Ocular ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Distribution of ocular biometry in young Chinese eyes: The Anyang University Students Eye Study.
Autorzy :
Sun Y; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Wei S; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Li S; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Cao K; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.; Beijing Institute of Ophthalmology, Beijing, China.
Hu J; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.; Beijing Institute of Ophthalmology, Beijing, China.
Yang X; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.; Beijing Institute of Ophthalmology, Beijing, China.
Lin C; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
An W; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.; Beijing Institute of Ophthalmology, Beijing, China.
Guo J; Anyang Eye Hospital, Henan Province, China.
Li H; Anyang Eye Hospital, Henan Province, China.
Fu J; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Wang N; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.; Beijing Institute of Ophthalmology, Beijing, China.
Pokaż więcej
Źródło :
Acta ophthalmologica [Acta Ophthalmol] 2021 Sep; Vol. 99 (6), pp. 621-627. Date of Electronic Publication: 2020 Dec 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pattern of cerebellar grey matter loss associated with ataxia severity in spinocerebellar ataxias type 3: a multi-voxel pattern analysis.
Autorzy :
Hu J; Department of Radiology, The First Affiliated Hospital of Fujian Medical University, 20 ChaZhong Rd, Fuzhou, Fujian, 350005, People's Republic of China.
Chen X; Department of Rehabilitation, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350005, People's Republic of China.
Li M; Department of Radiology, The First Affiliated Hospital of Fujian Medical University, 20 ChaZhong Rd, Fuzhou, Fujian, 350005, People's Republic of China.
Xu HL; Department of Neurology, 900TH Hospital of Joint Logistics Support Force, Fuzhou, China.
Huang Z; Department of Radiology, The First Affiliated Hospital of Fujian Medical University, 20 ChaZhong Rd, Fuzhou, Fujian, 350005, People's Republic of China.
Chen N; Department of Radiology, The First Affiliated Hospital of Fujian Medical University, 20 ChaZhong Rd, Fuzhou, Fujian, 350005, People's Republic of China.
Tu Y; Department of Radiology, The First Affiliated Hospital of Fujian Medical University, 20 ChaZhong Rd, Fuzhou, Fujian, 350005, People's Republic of China.
Chen Q; Department of Radiology, The First Affiliated Hospital of Fujian Medical University, 20 ChaZhong Rd, Fuzhou, Fujian, 350005, People's Republic of China.
Gan S; Department of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350005, People's Republic of China. .; Fujian Institute of Neurology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. .
Cao D; Department of Radiology, The First Affiliated Hospital of Fujian Medical University, 20 ChaZhong Rd, Fuzhou, Fujian, 350005, People's Republic of China. .; Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. .; Key Laboratory of Radiation Biology of Fujian Higher Education Institutions, the First Affiliated Hospital, Fujian Medical University, 20 ChaZhong Rd, Fuzhou, 350005, Fujian, China. .
Pokaż więcej
Źródło :
Brain imaging and behavior [Brain Imaging Behav] 2021 Aug 21. Date of Electronic Publication: 2021 Aug 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The evolution of acquired resistance to BRAF inhibitor is sustained by IGF1-driven tumor vascular remodeling.
Autorzy :
Xu G; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Luo Y; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Wu W; Department of Thyroid and Parathyroid Surgery Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Liu X; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Yu X; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Bao Y; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
He X; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Yu J; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Li Y; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Yang J; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Zhang R; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Yu C; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Chen H; Core Facility of West China Hospital, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Xu J; State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.
Hu J; College of Pharmacy and Biological Engineering, Sichuan Industrial Institute of Antibiotics, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Chengdu University, Chengdu, Sichuan 610106, China.
Jing J; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
Shi H; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China. Electronic address: .
Pokaż więcej
Źródło :
The Journal of investigative dermatology [J Invest Dermatol] 2021 Aug 03. Date of Electronic Publication: 2021 Aug 03.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Ptercresions A-C: a new terpene glycoside and two sesquiterpenes with hepatoprotective activity from Pteris cretica L.
Autorzy :
Hu J; Emergency Center, Suining Central Hospital, Suining, Sichuan, P. R. China.
Liu S; Department of Emergency Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, P. R. China.
Long Y; Respiratory Center, Suining Central Hospital, Suining, Sichuan, P. R. China.
Tao N; Emergency Center, Suining Central Hospital, Suining, Sichuan, P. R. China.
Yang B; Emergency Center, Suining Central Hospital, Suining, Sichuan, P. R. China.
Zhang L; Hepatobiliary pancreatic splenic surgery, Ya'an people's Hospital, Ya'an, Sichuan, P. R. China.
Pokaż więcej
Źródło :
Natural product research [Nat Prod Res] 2021 Jun 29, pp. 1-7. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systemic Bioinformatic Analyses of Nuclear-Encoded Mitochondrial Genes in Hypertrophic Cardiomyopathy.
Autorzy :
Tan Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wu L; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Fang Y; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Chen P; Department of Science and Technology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wan R; Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Shen Y; Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Hu J; Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jiang Z; Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Hong K; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.; Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Pokaż więcej
Źródło :
Frontiers in genetics [Front Genet] 2021 May 12; Vol. 12, pp. 670787. Date of Electronic Publication: 2021 May 12 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A commentary on "Efficacy of pulmonary rehabilitation in improving the quality of life for patients with chronic obstructive pulmonary disease: Evidence based on nineteen randomized controlled trials - A systematic review and meta-analysis" [Int. J. Surg. 73 (2020) 78-86].
Autorzy :
Hu J; Department of Emergency Medicine, Affiliated Hospital of North Sichuan Medical College, Emergency Center, Suining Central Hospital, Sichuan, China.
Long Y; Respiratory Center, Suining Central Hospital, Sichuan, 629000, China. Electronic address: .
Pokaż więcej
Źródło :
International journal of surgery (London, England) [Int J Surg] 2021 May; Vol. 89, pp. 105934. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Letter; Comment
MeSH Terms :
Pulmonary Disease, Chronic Obstructive*
Quality of Life*
Humans ; Randomized Controlled Trials as Topic
Opinia redakcyjna
Tytuł :
Specifically targeting Mtb cell-wall and TMM transporter: the development of MmpL3 inhibitors.
Autorzy :
Luo Q; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Duan H; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Yan H; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Liu X; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu 610065, China.
Peng L; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Hu Y; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Liu W; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Liang L; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Shi H; Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu 610065, China.
Zhao G; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Hu J; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Pokaż więcej
Źródło :
Current protein & peptide science [Curr Protein Pept Sci] 2021 Apr 20. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade.
Autorzy :
Liu X; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
Feng Y; Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 130022 Changchun, China; University of Science and Technology of China, Hefei, Anhui 230026, China.
Xu J; Institutes of Biological Sciences, Zhongshan-Xuhui Hospital, Fudan University, Shanghai 200032, China.
Shi Y; School of Medicine, University of Electronic Science and Technology of China, 610054 Chengdu, Sichuan, China.
Yang J; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
Zhang R; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
Song J; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
Bai X; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
Wu X; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
Bao Y; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
Luo Y; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
Li H; Research Core Facility, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China.
Chai L; Research Core Facility, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China.
Gong C; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China.
Wang Y; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, 100142 Beijing, China.
Chen B; Conmed Biosciences Inc, 610200 Chengdu, Sichuan, China.
Hu J; College of Pharmacy and Biological Engineering, Chengdu University, 610106 Chengdu, Sichuan, China.
Fu Y; The National Engineering Laboratory for Anti-Tumor Protein Therapeutics, Beijing Key Laboratory for Protein Therapeutics, Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing, China.
Luo Y; The National Engineering Laboratory for Anti-Tumor Protein Therapeutics, Beijing Key Laboratory for Protein Therapeutics, Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing, China.
Zhang H; Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 130022 Changchun, China; University of Science and Technology of China, Hefei, Anhui 230026, China. Electronic address: .
Shi H; Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2021 Apr 10; Vol. 332, pp. 194-209. Date of Electronic Publication: 2021 Feb 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immune Checkpoint Inhibitors*
Photothermal Therapy*
Cell Line, Tumor ; Gold/pharmacology ; Humans ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Linoleic acid inhibits in vitro function of human and murine dendritic cells, CD4 T cells and retinal pigment epithelial cells.
Autorzy :
Huang X; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, and Chongqing Eye Institute, Chongqing, People's Republic of China.
Yi S; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, and Chongqing Eye Institute, Chongqing, People's Republic of China.
Hu J; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, and Chongqing Eye Institute, Chongqing, People's Republic of China.
Du Z; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, and Chongqing Eye Institute, Chongqing, People's Republic of China.
Wang Q; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, and Chongqing Eye Institute, Chongqing, People's Republic of China.
Ye Z; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, and Chongqing Eye Institute, Chongqing, People's Republic of China.
Su G; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, and Chongqing Eye Institute, Chongqing, People's Republic of China.
Kijlstra A; University Eye Clinic Maastricht, Maastricht, Netherlands.
Yang P; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, and Chongqing Eye Institute, Chongqing, People's Republic of China. .
Pokaż więcej
Źródło :
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2021 Apr; Vol. 259 (4), pp. 987-998. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Journal Article
MeSH Terms :
Dendritic Cells*
Linoleic Acid*
Animals ; CD4-Positive T-Lymphocytes ; Cells, Cultured ; Humans ; Mice ; Retinal Pigments ; Th17 Cells
Czasopismo naukowe
Tytuł :
Ubiquitin-like protein FAT10 suppresses SIRT1-mediated autophagy to protect against ischemic myocardial injury.
Autorzy :
Wan R; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China. Electronic address: .
Yuan P; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Guo L; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Shao J; Department of General Surgery, the Second Affiliated Hospital of Nanchang University Nanchang of Jiangxi, 330006, China.
Liu X; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Lai W; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Kong Q; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Chen L; Department of General Surgery, the Second Affiliated Hospital of Nanchang University Nanchang of Jiangxi, 330006, China.
Ge J; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Xu Z; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Genetics Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Xie J; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Shen Y; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Genetics Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Hu J; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Zhou Q; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Yu J; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Jiang Z; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Jiang X; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Hong K; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of molecular and cellular cardiology [J Mol Cell Cardiol] 2021 Apr; Vol. 153, pp. 1-13. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Classification and Design of HIV-1 Integrase Inhibitors Based on Machine Learning.
Autorzy :
Zhou J; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Hao J; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Peng L; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Duan H; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Luo Q; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Yan H; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Wan H; College of Mathematics and Informatics, South China Agricultural University, Guangzhou 510106, China.
Hu Y; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Liang L; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Xie Z; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Liu W; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Zhao G; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Hu J; Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, School of Pharmacy, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China.
Pokaż więcej
Źródło :
Computational and mathematical methods in medicine [Comput Math Methods Med] 2021 Apr 01; Vol. 2021, pp. 5559338. Date of Electronic Publication: 2021 Apr 01 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Financial Self-Efficacy and General Life Satisfaction: The Sequential Mediating Role of High Standards Tendency and Investment Satisfaction.
Autorzy :
Hu J; Laboratory for Behavioral and Regional Finance, Guangdong University of Finance, Guangzhou, China.
Quan L; Laboratory for Behavioral and Regional Finance, Guangdong University of Finance, Guangzhou, China.
Wu Y; Laboratory for Behavioral and Regional Finance, Guangdong University of Finance, Guangzhou, China.
Zhu J; Laboratory for Behavioral and Regional Finance, Guangdong University of Finance, Guangzhou, China.
Deng M; School of Economics and Management, Wuhan University, Wuhan, China.
Tang S; Laboratory for Behavioral and Regional Finance, Guangdong University of Finance, Guangzhou, China.
Zhang W; School of Psychology, South China Normal University, Guangzhou, China.; Center for Studies of Psychological Application, South China Normal University, Guangzhou, China.
Pokaż więcej
Źródło :
Frontiers in psychology [Front Psychol] 2021 Mar 17; Vol. 12, pp. 545508. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A technique for quantifying the sensitivity of dosimetric tool gamma with 2D detector array in pretreatment IMRT plans by segment deletion method.
Autorzy :
Krishnan MPA; School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, India.; MVR Cancer Centre and Research Institute, Kozhikode, 673601, India.
Bhagyalakshmi AT; School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, India.
Holla R; Amrita Institute of Medical Sciences and Research Centre, Kochi, 682041, India.
Puzakkal N; MVR Cancer Centre and Research Institute, Kozhikode, 673601, India.
Ranjith CP; MVR Cancer Centre and Research Institute, Kozhikode, 673601, India.
Vysakh R; MVR Cancer Centre and Research Institute, Kozhikode, 673601, India.
Irfad MP; MVR Cancer Centre and Research Institute, Kozhikode, 673601, India.
Ramasubramanian V; School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, India.
Hu J; School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, India. .
Momeen MU; School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, India. .
Pokaż więcej
Źródło :
La Radiologia medica [Radiol Med] 2021 Mar; Vol. 126 (3), pp. 453-459. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article
MeSH Terms :
Radiotherapy Dosage*
Radiotherapy Setup Errors*
Head and Neck Neoplasms/*diagnostic imaging
Head and Neck Neoplasms/*radiotherapy
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*methods
Algorithms ; Humans ; Linear Models ; Particle Accelerators ; Radiometry/methods ; Radiotherapy, Intensity-Modulated/instrumentation ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1.
Autorzy :
Wu Q; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China; University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, China.
Chen DQ; Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
Sun L; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China; University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, China.
Huan XJ; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.
Bao XB; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.
Tian CQ; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China; University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, China.
Hu J; Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
Lv KK; University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, China; Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
Wang YQ; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China; University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, China. Electronic address: .
Xiong B; University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, China; Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China. Electronic address: .
Miao ZH; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China; University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, China. Electronic address: .
Pokaż więcej
Źródło :
Biochemical pharmacology [Biochem Pharmacol] 2021 Mar; Vol. 185, pp. 114435. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*pharmacology
Histone Acetyltransferases/*antagonists & inhibitors
Histone Acetyltransferases/*metabolism
Proteins/*antagonists & inhibitors
Proteins/*metabolism
TATA-Binding Protein Associated Factors/*antagonists & inhibitors
TATA-Binding Protein Associated Factors/*metabolism
Transcription Factor TFIID/*antagonists & inhibitors
Transcription Factor TFIID/*metabolism
A549 Cells ; Animals ; Dose-Response Relationship, Drug ; Female ; HCT116 Cells ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Inbred ICR ; Mice, Nude ; Tumor Burden/drug effects ; Tumor Burden/physiology ; Xenograft Model Antitumor Assays/methods
Czasopismo naukowe
Tytuł :
A20 Inhibits Intraocular Inflammation in Mice by Regulating the Function of CD4+T Cells and RPE Cells.
Autorzy :
Hu J; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.
Yi S; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.
Wang C; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.
Zhang Y; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.
Tang J; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.
Huang X; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.
Yang L; Department of Ophthalmology, The Second Hospital of Lanzhou University, Lanzhou, China.
Yang J; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.
Li H; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Feb 04; Vol. 11, pp. 603939. Date of Electronic Publication: 2021 Feb 04 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood-Retinal Barrier*
Chemotaxis, Leukocyte*
Autoimmune Diseases/*metabolism
CD4-Positive T-Lymphocytes/*metabolism
Epithelial Cells/*metabolism
Retinal Pigment Epithelium/*metabolism
Tumor Necrosis Factor alpha-Induced Protein 3/*metabolism
Uvea/*metabolism
Uveitis/*metabolism
Animals ; Autoimmune Diseases/immunology ; Autoimmune Diseases/pathology ; Autoimmune Diseases/prevention & control ; CD4-Positive T-Lymphocytes/immunology ; Case-Control Studies ; Cytokines/metabolism ; Disease Models, Animal ; Epithelial Cells/immunology ; Epithelial Cells/pathology ; Humans ; Mice ; Phenotype ; Retinal Pigment Epithelium/immunology ; Retinal Pigment Epithelium/pathology ; Signal Transduction ; Tight Junction Proteins/metabolism ; Tumor Necrosis Factor alpha-Induced Protein 3/genetics ; Uvea/immunology ; Uvea/pathology ; Uveitis/immunology ; Uveitis/pathology ; Uveitis/prevention & control
Czasopismo naukowe
Tytuł :
MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
Autorzy :
Han J; Respiratory and Critical Illness Ward 1, Henan Chest Hospital, No. 1, Weiwu Road, Zhengzhou, 450000, Henan, China.
Hu J; Respiratory and Critical Illness Ward 1, Henan Chest Hospital, No. 1, Weiwu Road, Zhengzhou, 450000, Henan, China. .
Sun F; Respiratory and Critical Illness Ward 1, Henan Chest Hospital, No. 1, Weiwu Road, Zhengzhou, 450000, Henan, China.
Bian H; Respiratory and Critical Illness Ward 1, Henan Chest Hospital, No. 1, Weiwu Road, Zhengzhou, 450000, Henan, China.
Tang B; Respiratory and Critical Illness Ward 1, Henan Chest Hospital, No. 1, Weiwu Road, Zhengzhou, 450000, Henan, China.
Fang X; Respiratory and Critical Illness Ward 1, Henan Chest Hospital, No. 1, Weiwu Road, Zhengzhou, 450000, Henan, China.
Pokaż więcej
Źródło :
Molecular and cellular biochemistry [Mol Cell Biochem] 2021 Feb; Vol. 476 (2), pp. 689-698. Date of Electronic Publication: 2020 Oct 30.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung/*blood supply
Lung Neoplasms/*blood supply
MicroRNAs/*metabolism
Phosphatidylinositol 3-Kinases/*metabolism
Proto-Oncogene Proteins c-akt/*metabolism
Ribonucleoside Diphosphate Reductase/*metabolism
Animals ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Cell Movement/physiology ; Cell Proliferation/physiology ; Computational Biology/methods ; Databases, Genetic ; Endothelial Cells/metabolism ; Female ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; MicroRNAs/genetics ; Middle Aged ; Neovascularization, Pathologic/genetics ; Neovascularization, Pathologic/metabolism ; Neovascularization, Pathologic/pathology ; Ribonucleoside Diphosphate Reductase/genetics ; Signal Transduction
Czasopismo naukowe
Tytuł :
Selenium-doped calcium phosphate biomineral reverses multidrug resistance to enhance bone tumor chemotherapy.
Autorzy :
Hu J; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China.
Jiang Y; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China.
Tan S; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China.
Zhu K; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China.
Cai T; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China.
Zhan T; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China.
He S; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China.
Chen F; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China. Electronic address: .
Zhang C; Department of Orthopaedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, PR China. Electronic address: .
Pokaż więcej
Źródło :
Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2021 Feb; Vol. 32, pp. 102322. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Clinical characteristics, rates of blindness, and geographic features of PACD in China.
Autorzy :
Zhang H; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Ophthalmology and Visual Science Key Lab.
Cao K; Beijing Institute of Ophthalmology.
Jia H; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Ophthalmology and Visual Science Key Lab.
Li L; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Ophthalmology and Visual Science Key Lab.
Hu J; Beijing Institute of Ophthalmology.
Liang J; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Song J; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Wang H; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Ophthalmology and Visual Science Key Lab.
Zhao A; Beijing Clinical Service Center.
Duan X; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Ophthalmology and Visual Science Key Lab.
Fan S; Handan City Eye Hospital, Handan, China.
Wang F; The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Su Y; The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ha S; Department of Ophthalmology, Ning Xia Eye Hospital, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
Duan X; The Second Xiangya Hospital of Central South University, Changsha, China.
Yu J; Xi'an Fourth Hospital.
Zhao C; Tang Shan City Eye Hospital.
Tang G; The First Hospital of Shijiazhuang City, Shijiazhuang, China.
Su Y; Baotou Chaoju Ophthalmic Hospital, Baotou, China.
Cai H; Tianjin Eye Hospital, Tianjin, China.
Gao J; Liaocheng People's Hospital, Liaocheng, China.
Qu Y; Yuncheng City Eye Hospital, Yuncheng City, China.
Lu P; Lanzhou University Second Hospital, Lanzhou, China.
Xie X; Eye Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zhao J; No. 1 Hospital of Xi 'An City, Xi'an,China.
Tang L; West China Hospital, Sichuan University, Chengdu,China.
Liu D; The Second Hospital of Heibei Medical University, Shijiazhuang,China.
Liu W; The Second People's Hospital of Jinan, Jinan,China.
Zhang M; Dongguan People's Hospital, Dongguan, China.
Fang A; The Eye Hospital of Wenzhou Medical University, Wenzhou, China.
Qu B; The 4th Affiliated Hospital of China Medical University, the Eye Hospital of China Medical University, Shenyang, China.
Dai W; Xuanwu Hospital, Capital Medical University.
Zhong H; The First Affiliated Hospital of Kunming Medical University.
Zhang X; The First People's Hospital of Xuzhou, Xuzhou, China.
Wu Z; Wuhan Aier Eye Hospital, Wuhan, China.
Zhai G; FuShun Eye Hospital, Fushun, China.
Lyu H; The Affiliated Hospital of Southwest Medical University, Chongqing, China.
Xie L; The Third Medical Center of Chinese PLA General Hospital.
Li H; The Third Medical Center of Chinese PLA General Hospital.
Zheng Y; The Second Hospital of Jilin University, Changchun, China.
Li N; Jinzhou Central Hospital, Jinzhou, China.
Li K; Zibo Central Hospital, Zibo, China.
Xie G; Baoji People's Hospital, Baoji, China.
Qu H; Shanxi Eye Hospital, Taiyuan, China.
Yu J; ShiYan People's Hospital, Shiyan, China.
Liang L; Yichang Central Hospital, Yichang, China.
Zhu M; The First People's Hospital of Foshan, Foshan, China.
Wang X; Harbin Ophthalmology Hospital, Harbin, China.
Ma X; Liuzhou People's Hospital, Liuzhou, China.
Zeng L; ChengDu First People's Hospital, Chengdu, China.
Liu X; Shenzhen Eye Hospital, Shenzhen, China.
Zhang Y; Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Zhang Y; Huashan Hospital of Fudan University, Shanghai, China.
Yu F; The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Zhu Y; The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Cheng S; Hebei Eye Hospital, Xingtai, China.
Yu M; Mian Yang Central Hospital, Mianyang, China.
Li J; The Second Hospital of Dalian Medical University, Dalian, China.
Zhang Y; Wuxi NO.2 People's Hospital, Wuxi, China.
Liu P; Taian Central Hospital, Taian City, China.
Wu Z; The Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Zhang X; Eye Hospital of NanYang City, Nanyang, China.
Kuo D; Palo Alto Medical Foundation, San Francisco, the United States.
Wang N; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Ophthalmology and Visual Science Key Lab; Beijing Institute of Ophthalmology.
Qiao C; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Institute of Ophthalmology. Electronic address: .
Pokaż więcej
Źródło :
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie [Can J Ophthalmol] 2021 Jan 21. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies